Drugs
Researchers at the 13th International AIDS Conference announced a new approach to using AIDS drugs that could ease the treatment burden for patients. This approach, dubbed "stop-and-go," involves stopping AIDS drugs for short periods and then replenishing them before the virus has a chance to get out of
Drugs
Developing countries have long struggled with accessing AIDS drugs, but recent announcements by pharmaceutical companies and foundations have sparked a new wave of hope. The International AIDS Conference in Durban, South Africa, has seen numerous declarations from companies willing to reduce prices or provide drugs at a discount. However, health
Drugs
Top AIDS researchers have concluded that the standard treatment for AIDS patients should be changed from the single-drug therapy AZT to a combination of medications. Two new studies, the European-Australian Delta study and the U.S. AIDS Clinical Trials Group (ACTG) 175 report, have shown that a combination of drugs
Drugs
Researchers at an international AIDS meeting are exploring the use of snake and scorpion venom as novel medications to combat the global AIDS epidemic. The studies, while promising, have sparked skepticism among some experts, highlighting the desperation to find new treatments as the virus becomes increasingly resistant to mainline therapies.
Pharmaceutical industry
A federal advisory group, the National Task Force on AIDS Drug Development, has warned that the pharmaceutical industry is rapidly abandoning research on new AIDS drugs due to limited profits. The task force, composed of patients, drug makers, and government and private scientists, has urged the government to provide tax
AIDS (Disease)
A alarming trend of exogenous reinfection with multidrug-resistant tuberculosis (MDR-TB) has been reported among AIDS patients being treated for drug-susceptible disease at a Bronx treatment center. Over a two-year period, 250 patients with TB were identified at the Lincoln Medical and Mental Health Center, with three cases of rifampin-isoniazid-streptomycin-ethambutol (RISE)
AIDS (Disease)
The study aimed to investigate the factors contributing to mortality in tuberculosis (TB) patients, particularly in those with Human Immunodeficiency Virus/AIDS (HIV/AIDS). The researchers conducted a retrospective case-control study of patients admitted to hospitals between 1988 and 1993. The analysis revealed distinct differences in the circumstances surrounding death
AIDS (Disease)
A broad new initiative to evaluate and enhance HIV prevention strategies in the United States is being launched by a coalition of prominent health organizations, including the Kaiser Family Foundation, the Harvard AIDS Institute, the Center for AIDS Prevention Studies at the University of California, San Francisco, and Family Health
AIDS (Disease)
In a conference convened by the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, entertainment industry executives and academic experts urged the CDC to request regular airing of condom ads on network television, citing research that consistently shows condom use dramatically decreases HIV/AIDS and other
